Skip to content
newprotein.net Explore ingredients
Menu
Pale pink cultivated fish cells forming a translucent fillet on a scaffold over blue coastal water with a sushi plate nearby

Cultivated (cell-based) products

Cultivated seafood: fish cells, media and regulation

By the New Protein editorial team · Reviewed · 6 min read

Cultivated seafood explained: fish cell lines, species-specific media, structuring methods, the FDA consultation on salmon cells, Singapore and EU rules.

Strong at
Water binding
Diet
Animal
Allergens
Fish
Group
Cultivated (cell-based) products

What cultivated seafood is and how it is made

Cultivated seafood is fish or shellfish tissue grown from cultured animal cells in bioreactors. A developer isolates cells from a fish, such as coho salmon, establishes a cell line and cell bank, and expands the cells in a nutrient medium. The cell mass is then harvested and shaped into fillets, minced products or blends with plant protein.

Seafood has its own science. The field of blue food technology covers cell-based mariculture, plant-derived blue foods, fermentation-derived products and microalgae, and a 2026 review reports that more than 60 million United States dollars had been allocated to cell-cultivated blue food technologies by 2020. Aquatic cells pose problems that mammalian protocols do not solve.

Structure and texture require engineering. The same review describes extrusion, electrospinning, wet spinning and three-dimensional printing as structuring technologies for fish-like textures. Producers of cultivated fillets combine cell mass with scaffolds, plant proteins and fats, and work to recreate the flake and moisture that consumers expect from cooked fish, which remains hard.

Culture media and production challenges for cultivated seafood

Culture media are the heart of cost and difficulty. A 2026 review states that over a decade of research on media for cultured meat and seafood has produced efficient serum-free and chemically defined formulations for some species, but has also found challenges yet to be solved, especially for aquatic cell lines. Approaches diverge greatly with product and cell type.

Fish cells are not simply mammalian cells at lower temperature. The review notes that bovine serum is not an ideal proliferation-promoting component for fish cells, and that replacing it with gilthead seabream serum improved proliferation and extracellular matrix mineralisation in two seabream cell lines. That result illustrates why species-specific growth factors are a priority research topic.

Cost strategies are still being defined. The media review lists hydrolysates, growth factor mutants, growth factor alternatives and stabilisers as options for lower-cost serum-free media, as well as waste medium recycling and the potential use of artificial intelligence. It also proposes performance indicators for media, which would allow developers to compare formulations on productivity, price and food compatibility.

Scale is the second challenge. The industrialisation review reports that approvals now exist, but market-wide pricing remains unattainable, and a United States stakeholder study names taste and price parity and production at scale as key sector challenges. For seafood, the same cost logic applies as for meat, since media and bioreactor productivity set the price per kilogram.

Regulation in the United States

FDA treats seafood from cultured cells differently from meat. Its page explains that FDA regulates processing and the foods themselves made from the cultured cells of animals not regulated under the meat and poultry inspection acts, giving seafood as an example. USDA-FSIS shares jurisdiction only for livestock and poultry products, so a fish product follows the FDA route.

The FDA’s voluntary pre-market consultation evaluates the production process and the cell material, including cell lines, cell banks, manufacturing controls and inputs. The inventory of completed consultations lists cultured coho salmon cell material as file 000005, with a submission dated June 2022 and FDA responses dated in May 2025. The consultation is not an approval.

Imports are covered. FDA states that imported human food made from cultured cells from fish and seafood is treated like other FDA-regulated food, so importers need to meet the same requirements. Other food law applies as well, including labelling, facility registration and food safety rules, so the consultation is only one element of a launch.

Regulation in Singapore, the EU and elsewhere

Singapore introduced a novel food framework in 2019, and the Singapore Food Agency classes cultured or cell-based products among the alternative proteins that must be assessed for safety before sale. An expert working group formed in March 2020 provides scientific advice. SFA also states that misrepresenting cultured products as conventionally produced foods will not be allowed.

In the European Union, products from cell or tissue cultures are novel foods under Regulation 2015/2283, and each requires an EFSA assessment and authorisation, according to the industrialisation review. It adds that Europe and the UK focus on defined media and structured novel food rules, with early commercialisation mainly in pet food, so seafood launches depend on future authorisations.

Approvals elsewhere include salmon. A mid-2025 review lists regulatory approvals in Singapore, the United States and Australia for products such as chicken, quail, salmon and pork fat from GOOD Meat, UPSIDE Foods, Wildtype, Mission Barns and Vow, and notes that numerous jurisdictions impose legislative bans or regulatory obstacles. Buyers must check each market separately.

Applications and uses

Premium fillets and raw-style dishes are the headline products. Cultured salmon is aimed at fillet applications where texture and fat distribution matter, and small portions suit the cost level that current production allows. A comparison with the red meat equivalent is given on the page for cultivated meat, including regulatory differences between the two.

Plant-based seafood is a separate route and should not be confused with cultivated products. Plantish, an Israeli start-up, presented a whole-cut salmon fillet in January 2022 that is entirely plant-based and produced with additive manufacturing, with no fish cells involved. Such analogues follow the ordinary food rules for their ingredients, while cultivated seafood needs pre-market review.

Hybrid products blend cell mass with plant protein. A mix of cultivated fish cells with seaweed protein, legume protein and fat can reduce cost while delivering marine flavour, and plant-based seafood analogues made without animal cells compete in the same category. Formulators weigh cell content, label wording, allergen position and price.

Other alternatives for fish flavour include fermentation-derived ingredients, plant proteins and algae. The entries on spirulina and mushroom root show how algae and fungi supply colour, umami and texture for seafood-style products, and they can be combined with cultivated cells in a single recipe when cost or supply requires it.

Allergen and safety status

Fish is a major food allergen, and cultivated seafood made from fish cells carries the source species allergens. Labels must therefore declare fish, and allergen management in production and food service follows the same rules as for conventional fish. People with fish allergy should not assume that animal-free growth conditions remove the risk.

The safety dossier covers cell lines, culture components and process controls. FDA evaluates cell banks, manufacturing controls and all components and inputs, and a 2026 review of cell lines argues that regulatory dossiers differ substantially in cell line qualification and banking practice. Aquatic species add questions about species-specific growth factors and media components.

Residues and contaminants are further topics. Producers must show that media components, scaffolds and process aids are absent or acceptable in the final product, and that microbiological quality is controlled. Buyers should ask for analytical data on heavy metals and other contaminants, since cultured cells are grown in closed systems but the inputs still matter.

Sourcing and supply

Supply is limited to a small number of companies, mostly at pilot scale. The industrialisation review identifies Wildtype as one of the companies with approvals covering salmon, and describes commercialisation as preliminary. Volumes are small, and buyers should expect restaurant-scale supply, with small lots and high prices for the foreseeable future.

Procurement questions include species, cell line origin, regulatory status in each market, culture medium composition, cell content of the product and shelf life. Ask for specifications covering protein, fat, omega-3 content, moisture and microbiology, an allergen statement, and the file reference for each regulatory consultation. Confirm that labelling approved in your market matches the intended claims.

Planning should assume change. Regulatory approvals, bans and labelling rules continue to move, and stakeholder interviews describe funding declines after a boom. Seafood teams should keep plant-based, fermentation-based and algae options in the roadmap, and monitor FDA, SFA and EFSA announcements before fixing launch dates or marketing claims in any country.

Frequently asked questions

What is cultivated seafood?

Cultivated seafood is fish or shellfish tissue grown from cultured animal cells in bioreactors, not from a wild catch or farmed animal. Producers expand cells from species such as salmon, then harvest and shape the cell mass into fillets or blended products.

Has cultivated seafood been cleared in the US?

FDA completed a pre-market consultation on cultured coho salmon cell material, listed as file 000005 in its inventory with responses dated in 2025. A mid-2025 review also lists approvals for salmon among products from Wildtype in the United States.

Who regulates it in the US?

FDA regulates processing and the foods themselves for cultured cells of animals not covered by the meat and poultry inspection acts, with seafood given as an example. Cultured livestock and poultry products are shared with USDA-FSIS.

Why is culture medium harder for fish cells?

Research on media is advanced for mammalian cells, but a 2026 review says challenges remain especially for aquatic cell lines, including species-specific growth factors. Bovine serum is not an ideal proliferation promoter for fish cells, and seabream serum worked better in one study.

Is cultivated seafood vegan or allergen free?

It is made from animal cells, so it is not vegan, and it carries the allergen of the source species. Fish is a major allergen, so labels must declare it, and people allergic to fish should treat cultivated fish as unsafe unless advised otherwise.